If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.84    -0.11 (-2.22%)
Bid:
4.84
Ask:
4.85
Spread: 0.01 (0.207%)
Market Cap: £42.09m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

FY25 Trading Update

23 Jan 2025 07:00

RNS Number : 3669U
Revolution Beauty Group PLC
23 January 2025
 

 

23 January 2025

 

Revolution Beauty Group plc

 

("Revolution Beauty", the "Group", or the "Company")

 

FY25 Trading Update

 

Revolution Beauty Group, the multi-channel mass beauty brand, is today providing an update on trading for the year ending 28 February 2025 ("FY25").

 

FY25 is a transformational year for Revolution Beauty, during which it has discontinued over 6,000 unproductive SKUs - some 75% of its original portfolio - to create a scalable and profitable foundation for future growth. The Company continues to transition its global retailers onto this core set of products.

 

Revolution Beauty also continues to make encouraging progress expanding its relationships with existing and new retailers. However, certain retailer launches that were expected in Q4 25 will now take place in H1 26. The scale of these opportunities remains the same, and the launches into Walmart in the US and DM in Germany remain on track for February 2025.

 

In addition to this phasing impact, the Company experienced some sales softness in December 2024 in its digital channels and an element of de-stocking from USA retailers. As a result, the Company now expects net sales for FY25 to decline c.25% and high single digit millions underlying adjusted EBITDA supported by the continued positive delivery of our operational and cost savings programmes. The one-off stock provision for the non-strategic discontinued stock announced in the interim results remains unchanged. We continue to be in compliance with our banking covenants with sufficient liquidity headroom. Our cash balances were £6m at the end of December 2024 and net debt was £26m including a fully drawn RCF of £32m.

 

The Company's core SKUs continue to grow, including through channels such as Amazon, which are performing well in both the USA and Europe.

 

Looking ahead, Revolution Beauty is confident in a return to overall growth in FY26, as new strategic growth initiatives such as the launch of the new SKIN brand, the relaunch of our value brand RELOVE, and as the core SKU growth accelerates globally. This will be underpinned by significant margin improvements in the medium term.

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information please contact:

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

Panmure Liberum Limited (Nomad and Joint Broker): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

Zeus (Joint Broker): Benjamin Robertson / Nick Cowles / Jordan Warburton

Tel: +44 (0) 161 831 1512

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBTMTTMTMTTRA
Date   Source Headline
12th Mar 20258:57 amRNSHolding(s) in Company
7th Mar 20252:47 pmRNSHolding(s) in Company
28th Feb 20253:08 pmRNSTotal Voting Rights
24th Feb 20258:52 amRNSHolding(s) in Company
21st Feb 20251:50 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20252:24 pmRNSHolding(s) in Company
23rd Jan 202510:44 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSFY25 Trading Update
2nd Jan 20257:00 amRNSUpdate on claim alleged by Chrysalis Investments
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 202411:54 amRNSHolding(s) in Company
13th Dec 20241:05 pmRNSHolding(s) in Company
12th Dec 202410:42 amRNSHolding(s) in Company
11th Dec 20243:15 pmRNSHolding(s) in Company
2nd Dec 20243:25 pmRNSTotal Voting Rights
2nd Dec 20243:24 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSInterim Results
8th Nov 20247:00 amRNSNotice of HY25 Results
4th Nov 20247:00 amRNSNominated Adviser and Broker
4th Nov 20247:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSHY2025 Trading Update
7th Oct 202412:40 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSRelated party transactions
5th Sep 20244:56 pmRNSHolding(s) in Company
30th Aug 20244:11 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:59 pmRNSAnnual General Meeting
29th Jul 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jul 20247:00 amRNSNotice of Retail Investor Presentation
3rd Jul 20245:00 pmRNSNotice of AGM and posting of Annual Report
1st Jul 202412:00 pmRNSTotal Voting Rights and NOMAD name change
26th Jun 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 29 FEBRUARY 2024
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.